Curing the Symptoms of a Sinusitis Infection

Sinusitis infections are a common condition which many people suffer from each year. There are many factors which contribute to a sinusitis infection. Frequently, the sinusitis will begin because of a cold or allergy though it can also develop because of fungal infections, reflux disease, and many other diseases such as cystic fibrosis. The sinusitis itself begins when the sinus cavity lining becomes swollen, usually because of a cold or allergy. When bacteria enter the sinus cavities and attack the swollen lining, greater inflammation occurs which causes the cilia, which usually flushes out mucus and bacteria that pollute the sinus cavities, to not function properly and therefore the bacteria and mucus become trapped which then causes the sinusitis infection.

There are many types of symptoms that may be experienced with a sinusitis infection. Some of the most common symptoms which may appear as cold like symptoms are cough, congestion, postnasal drip, green nasal discharge, and facial pain and pressure. A person may also experience a headache or even tooth pain due to the pressure of the inflammation pushing on the nerves in face. When the sinusitis infection lasts for twelve or more weeks it is then considered chronic sinusitis. With chronic sinusitis a person may also experience loss of sense of taste and smell and they also may become fatigued. Depending on which sinus cavity that the infection lies, there may also be other symptoms experienced.

There are several treatments which are used to treat a sinusitis infection. One common treatment which is used is over the counter or prescribed nasal sprays. Nasal sprays work by distributing saline solution or medication up into the sinuses. The nasal sprays however have a large particle size that cannot make it past the inflammation at the opening of the sinus cavities and up to where the infection lies. The nasal sprays may only offer relief to the lower part of the sinuses. Oral antibiotics are also a commonly prescribed medication by physicians. Oral antibiotics work on many types of infections by flowing through the blood stream to the area of infection. The sinus cavities only contain a small amount of blood vessels therefore it is difficult for an efficient amount of antibiotic to arrive at the sinusitis infection. Oral antibiotics also can cause problems throughout the rest of the body, such as abdominal pain. Another newer form of treatment is aerosolized medications. Aerosolized medications work great because they are directly distributed into the sinus cavities so that they can cure the problem where it started.

Home remedies are also frequently used. Some people may breathe in hot steam. The steam is meant to help moisturize the sinuses and help thin the mucus. Though the steam may offer temporary relief and help some symptoms, in there is in fact an infection, only antibiotics may help cure it. Irrigation is also another common home remedy. Irrigation is used by inserting saline solution in to the sinus cavities to also help moisten them. Just like steam, this may only offer temporary relief and medication will need to be used.

Another option in treating a sinusitis infection when all other treatments have failed is sinus surgery. Sinus surgery is painful, can leave scar tissue which can lead to future problems, and usually only offers temporary relief since only a portion of the inflammation and infection is removed and so the sinusitis infection often returns.

Just like in any medical condition, different treatments work for different people. In sinusitis it all depends on what stage the sinusitis is in along with other factors. What is important is finding the treatment form that works best for you and treating the sinusitis before it gets to a chronic stage that may create more problems and involve more extreme treatment options.

About the Author
More sinusitis infection treatment information like Aerosolized Sinusitis Therapy can be found at Sinus Infection Problem - Sinus Dynamic

Himalayan Sea Salt versus White Table Salt

Learn the difference between commercial salt and natural, organic, gourmet Himalayan sea salt crystal. Most people buy iodized salt from the grocery store and don't think a thing about it. They don't realize that good Himalayan sea salt can help give them good health, while refined salt can create some health risks. Salt comes from the sea. It may have been laid down centuries ago in salt deposits, or it may have been dehydrated from pure seawater. Grocery store salt is different from salt from natural sources. It has been heated-up to 1200° F.!-and refined to remove most of the natural elements. Grocery store salt is mostly chemical sodium chloride, while natural Himalayan sea salt has up to 84 natural minerals in it.

Your body craves natural salt. In fact, your blood actually contains 0.9% salt, which maintains the delicate balance of sodium throughout your body. Just about every system in your body needs good Himalayan sea salt to make it work. It is especially important for your nervous system, but every body structure absolutely requires it. The National Academy of Sciences advises that we consume at least 500 mg. of sodium a day to maintain good health. How much a person actually needs varies quite a bit, depending on their genetics and daily routine.

Popular diets say you should reduce or even eliminate dietary salt for good health, especially for cardiovascular disease. However, studies from Scotland, Finland and the United States showed little or no correlation between reducing your salt intake and reducing coronary heart disease. Perhaps refined table salt, which can act like a poison in your body, can be more of a risk. But the research is undeniable: reducing or eliminating dietary salt is basically wrong. Your body absolutely requires salt, but it has to be the right kind. Pure, natural unrefined Original Himalayan Sea Crystal Salt™ is such a salt. It gives you the healthy nutrients you need, in a form your body can use. It is pink because of the natural minerals in it! Gourmets say Himalayan sea salt tastes fantastic, with a richness you may have never tasted before from grocery store salt.

Natural health practitioners are convinced that good Himalayan crystal sea salt can improve your health. It keeps you safe and healthy during exercise; in fact, high-altitude hikers make sure they get enough so they don't go into hyperthermia. Taking adequate dietary salt has improved and even eliminated Chronic Fatigue Syndrome. Hypertension and stomach cancer have been linked to salt imbalance from improper dietary intake. Cystic fibrosis has been linked to improper salt metabolism. Expectant mothers are always advised to take enough salt in order to help create a healthy infant.

If you've never tried good Himalayan sea salt, you are going to be amazed at how good it tastes and how affordable it is. You may also be surprised at how quickly your health improves from using good, natural, organic Himalayan sea salt.

About the Author
Isabella founded http://www.solaywellness.com after learning how beneficial natural salt is and about it's many uses, as well as how it can be used to help people look and feel better and live healthier. Visit Solay wellness for all of your natural home needs, personal care, plant food and gourmet salts.

mortality in patients with cystic fibrosis

The majority of patients with cystic fibrosis die in early adulthood of lung disease. Lung transplantation is a treatment option for patients with advanced pulmonary disease, although the waiting period for organs may be as long as two years. Our purpose was to determine whether the risk of death due to respiratory failure could be predicted one or two years in advance on the basis of pulmonary function, blood gas levels, and nutritional status.

The study cohort consisted of 673 patients followed between 1977 and 1989. In each patient, pulmonary function, blood gas levels, nutritional status, and vital status were assessed between 1977 and 1987. Cox proportional-hazards regression analysis was used to compute the relative risk of death within one or two years after particular measurements. The effects of age and sex on mortality were also included in the analysis.

One hundred ninety patients (28 percent) died during the study period. Overall, patients with a forced expiratory volume in one second (FEV1) less than 30 percent of the predicted value, a partial pressure of arterial oxygen below 55 mm Hg, or a partial pressure of arterial carbon dioxide above 50 mm Hg had two-year mortality rates above 50 percent. Among the laboratory measurements, the FEV1 was the most significant predictor of mortality, but age and sex were also significant in predicting risk. After adjustment for age and sex, the relative risk of death within two years was 2.0 (95 percent confidence interval, 1.9 to 2.2) for each decrement in the FEV1 of 10 percent below the predicted value. Among patients with the same FEV1, the relative risk of death was 2.0 (95 percent confidence interval, 1.5 to 2.6) in patients 10 years younger than other patients, and 2.2 (1.6 to 3.1) in female patients as compared with male patients.

Patients with cystic fibrosis should be considered candidates for lung transplantation when the FEV1 falls below 30 percent of the predicted value. Female patients and younger patients may need to be considered for transplantation at an earlier stage.

Nasal Polyps in Cystic Fibrosis

Nasal polyps frequently appear in patients with cystic fibrosis (CF). The aims of this study were to focus on what problems (symptoms, endoscopic findings, and laboratory correlates) nasal polyps cause the CF patient, and how these correlate to the total health situation of this patient group.

The clinical histories, endoscopic investigations of the nasal cavity, and analyses of nasal lavage fluid of 44 patients with CF complicated with nasal polyposis have been compared with those of 67 CF control subjects. The patients were examined at annual control examinations (with pulmonary tests, working capacity, liver tests, and bacterial and blood tests) from 1995 to 1996 at Stockholm Cystic Fibrosis Center, Huddinge University Hospital. All patients were > 2 years of age. The endoscopic findings were related to the actual pulmonary function, inflammatory blood parameters, colonizing pathogens, antibodies (Staphylococcus aureus and Pseudomonas aeruginosa), and genotype.

The patients with nasal polyps differed with respect to chronic colonization of P aeruginosa in sputum samples and had a higher occurrence of serum antibodies against the same species. The two groups did not differ in pulmonary functions, inflammatory parameters, or genotype. The polyps found were mainly small (within the meatus media) and gave no significant increase in ongoing clinical symptoms such as rhinorrhea, nasal obstruction, or hyposmia. Neither was any significantly marked finding concerning the nose (mucosal swellings, secretion, etc.) made in the polyp patients. The patients with CF scored slightly lower in a smell identification test in comparison with the healthy control group. The nasal lavage fluid was analyzed (in 93 of the 111 patients) for the occurrence of P aeruginosa (by polymerase-chain reaction [PCR]), interleukin [IL]-5, IL-8, and lysozyme. The lysozyme and IL-8 content was equal in the two CF groups but increased in comparison with the healthy control group. P aeruginosa was not detected with PCR in any nasal lavage fluid. No measurable levels of IL-5 in the nasal lavage were found.

There was a higher frequency of chronic colonization of P aeruginosa in the lower respiratory tract in patients with nasal polyps. Otherwise, nonsevere nasal polyposis was not an indicator of lower respiratory tract morbidity in CF patients.

Vitamin E: Why It Is Important

Vitamin E Vitamin E is a very important vitamin to humans. This vitamin is fat soluble, which means that it can be stored by the body. There are actually eight different forms of vitamin E, and each form has it's own activity in the body. The most common form of this vitamin is called Alpha-tocopherol.

Fatty Acid Deficiency and Cystic Fibrosis

Cystic Fibrosis is a disease that results in excess mucus being trapped in the lungs. It is most often associated with a deficiency of essential fatty acids. Consuming more, often in the form of fish oils, is a great way to get relieve from the symptoms of Cystic Fibrosis.

David P. Katz wrote an article called Seriously Ill Cystic Fibrosis (Nutrition, Vol. 12, No. 5, 1996) that states those individuals who are not unable to absorb fats and various nutrients need to increase their consumption of essential fatty acids. Most people who have been diagnosed with Cystic Fibrosis have an essential Omega 6 fatty acid deficiency. Consuming enough fish oil can help reduce the inflammation experienced.

There have been many studies involved to establish the link between the need for fish oil supplements to control Cystic Fibrosis. In almost every study it was found that taking such a supplement did help the patients. A article written by Lawrence and T. Sorrell (Lancent, Vol. 342, August 21, 1993) explains the research they did regarding the effects of fish oil supplements on patients with Cystic Fibrosis. Half of the patients received a fish oil capsule with 2.7g of EPA. The other half of the patients got a placebo of an olive oil capsule. This was done daily for a six week period of time. Those who took the EPA ended up with less mucus in their lungs, they were able to breath easier, and they felt better.

Due to the positive effects that essential fatty acids have for those with Cystic Fibrosis, it is a good idea for them to consider adding such supplements to their daily diet. This can be in the form of fish oil supplements and Vitamin E because of the antioxidant properties.

The research has shown that essential fatty acid deficiencies can be linked to Cystic Fibrosis so make sure you take the necessary daily value to protect yourself from such ailments. Take fish oil supplements and increase the amount of fish and walnuts. You consume.

About the Author
You can also find more information at golden flax seed and magnesium phosphorus. OmegaFlaxSeedOil.com is a comprehensive resource to help individuals gain the benefits of essential nutrition s

women with cystic fibrosis

To determine the prevalence of urinary incontinence in female patients (aged 15 years) attending a cystic fibrosis centre, in whom stress UI could be common, as chronic coughing and sputum production are frequent symptoms associated with progressive lung disease in these patients.

Patients and methods An anonymous questionnaire was completed by 176 women with cystic fibrosis (mean age 24.6 years, sd 5.8) during routine assessments as outpatients.

In all, 72 patients (41%) were classified as never incontinent; occasional UI was reported in 61 women (35%). Regular UI, occurring twice or more a month for at least two consecutive months in the last year, was reported in 43 patients (24%). Regular UI was associated with increasing age and a lower mean ( sd) forced expiratory volume/s (of that predicted) than in women with no urinary symptoms, at 26.9 (6.5) years and 53.5 (23.5)%, and 23.1 (5.4) years and 65.5 (23.2)%, respectively (P < 0.01 and P < 0.05, respectively). All incontinent women recorded stress UI; coughing, laughing and physical activity were associated with UI in 92%, 33% and 21% of the patients, respectively.

Stress UI is a common symptom in women with cystic fibrosis. As urine loss can be under-reported to the healthcare providers, women should be asked about incontinence as part of their routine follow-up. Pelvic floor muscle exercises are effective in treating stress UI and should be considered for those with women with cystic fibrosis and regular UI.

Liver Disease In Cystic Fibrosis

The median age of the population with cystic fibrosis (CF) has increased worldwide, which has led to the suggestion that the prevalence of liver disease would increase. The aim of this study was to evaluate the natural history of CF-associated liver disease over a 15-year period in a well-controlled population of patients with CF.
During the years 1976 through 1993, 124 patients were followed up by yearly liver function tests (LFTs). Fifteen patients were followed up with liver biopsies throughout the whole study period. More than 50% of the patients had pathological LFTs in infancy, later being normalized. Approximately 25% of children 4 years of age or older had biochemical markers of liver disease during the study period. In about 10% of the patients, cirrhosis or advanced fibrosis was confirmed at biopsy and 4% of patients had cirrhosis with clinical liver disease. Severe liver disease developed mainly during prepuberty and puberty. Of the 15 patients prospectively followed up with liver biopsies, only 3 had progressive fibrosis.
No specific risk factor was identified, but deficiency of essential fatty acids was found more often in patients with marked steatosis (P < .05).
No patient developed clinical liver disease in adulthood and the histological changes in the liver biopsies were usually not progressive.
Liver disease was no more frequent at the end of the study period although the median age of the patient population had increased. Modern treatment might positively influence liver disease because it seemed less common, less progressive, and less serious than previously reported.

Aberrant CFTR

Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Initially, Cl- conductance in the sweat duct was discovered to be impaired in CF, a finding that has been extended to all CFTR-expressing cells. Subsequent cloning of the gene showed that CFTR functions as a cyclic-AMP-regulated Cl- channel; and some CF-causing mutations inhibit CFTR Cl- channel activity.
The identification of additional CF-causing mutants with normal Cl- channel activity indicates, however, that other CFTR-dependent processes contribute to the disease. Indeed, CFTR regulates other transporters, including Cl(-)-coupled HCO3- transport. Alkaline fluids are secreted by normal tissues, whereas acidic fluids are secreted by mutant CFTR-expressing tissues, indicating the importance of this activity. HCO3- and pH affect mucin viscosity and bacterial binding. We have examined Cl(-)-coupled HCO3- transport by CFTR mutants that retain substantial or normal Cl- channel activity.

Here we show that mutants reported to be associated with CF with pancreatic insufficiency do not support HCO3- transport, and those associated with pancreatic sufficiency show reduced HCO3- transport.
Our findings demonstrate the importance of HCO3- transport in the function of secretory epithelia and in CF.

Nutritional Benefits for Cystic Fibrosis

Background Many patients with cystic fibrosis are malnourished at the time of diagnosis. Whether newborn screening and early treatment may prevent the development of a nutritional deficiency is not known.

Methods We compared the nutritional status of patients with cystic fibrosis identified by neonatal screening or by standard diagnostic methods. A total of 650,341 newborn infants were screened by measuring immunoreactive trypsinogen on dried blood spots (from April 1985 through June 1991) or by combining the trypsinogen test with DNA analysis (from July 1991 through June 1994). Of 325,171 infants assigned to an early-diagnosis group, cystic fibrosis was diagnosed in 74 infants, including 5 with negative screening tests. Excluding infants with meconium ileus, we evaluated nutritional status for up to 10 years by anthropometric and biochemical methods in 56 of the infants who received an early diagnosis and in 40 of the infants in whom the diagnosis was made by standard methods (the control group). Pancreatic insufficiency was managed with nutritional interventions that included high-calorie diets, pancreatic-enzyme therapy, and fat-soluble vitamin supplements.

Results The diagnosis of cystic fibrosis was confirmed by a positive sweat test at a younger age in the early-diagnosis group than in the control group (mean age, 12 vs. 72 weeks). At the time of diagnosis, the early-diagnosis group had significantly higher height and weight percentiles and a higher head-circumference percentile (52nd, vs. 32nd in the control group; P = 0.003). The early-diagnosis group also had significantly higher anthropometric indexes during the follow-up period, especially the children with pancreatic insufficiency and those who were homozygous for the F508 mutation.

Conclusions Neonatal screening provides the opportunity to prevent malnutrition in infants with cystic fibrosis.

Cystic Fibrosis And Omega 3

The primary aim of medical and scientific research on cystic fibrosis is to understand, treat and cure cystic fibrosis. An inherited disease, cystic fibrosis is thought to affect about 30,000 Americans and is the most common, life-shortening genetic disease known. Cystic fibrosis is a life-threatening disease caused by a defective gene and affecting about 30,000 children in America.

Researchers from the Beth Israel Deaconess Medical Centre, the University of Massachusetts and Massachusetts General Hospital took tissue samples from 38 patients with cystic fibrosis. It was found they had extremely high levels of arachidonic acid (AA) and abnormally low levels of docosahexaenoic acid (DHA). People who did not have CF did not have the fatty acids imbalance.

Researchers believe that many of the symptoms of cystic fibrosis follow the same pattern: mutated gene produces a mutated glycoconjugate resulting in a defective cellular component. There are approximately ten million symptomless carriers of the defective cystic fibrosis gene in America.

They say too much of one acid and too little of another means patients' bodies are more prone to inflammation. In the New England Journal of Medicine, they suggest Omega-3 oils, found in fish, could help correct the imbalance.

Each week three young people in the UK die from the disease, which is caused by the faulty CFTR gene. CF causes an abnormally thick, sticky mucus to be produced in the body, causing chronic inflammation of the lungs leading to life-threatening infections. The average life expectancy for a person with CF is around 31.

To diagnose cystic fibrosis, the laboratory carries out a sweat test. When the lungs and airways are choked, the cystic fibrosis patient coughs and produces very thick sputum. The authors concluded that forced ionisation of the indoor air represents a natural and efficient treatment for respiratory diseases in patients with cystic fibrosis.

When the cystic fibrosisTR is not normal, the regulation of salt through the membranes becomes defective. In the respiratory system the thin mucus lining becomes thick and sticky. As the digestive juices do not reach the intestine, due to blocked ducts from the pancreas and liver, the fats and protein are not digested.

Dr Steven Freedman of the gastroenterology division at Beth Israel Deaconess Medical Center, who led the research, said: "Since 1989, we have known that the defective CFTR gene is responsible for CF. "But we didn't understand how this defective gene leads to the symptoms of the disease. "This new study sheds light on what may be happening and provides a link between CFTR function and fatty acid metabolism." He added: "It is known that high amounts of AA and low amounts of DHA would predispose to inflammation. "This discovery may help explain why there is an excessive inflammatory response among CF patients. "This is the basis for why Omega-3 fish oils, found in cold-water fish as well as supplements, reduce inflammation since they increase levels of DHA and suppress AA." 'No diet change'

Dr Adam Jaffe, head of the CF Research Group at London's Institute of Child Health, told BBC News Online the research was interesting but not conclusive. "Patients shouldn't change their diet based on spurious associations between fatty acids and inflammation. "But I would not be against them adding supplements to their diets."

About the Author
Tom O`Connor is an expert on the benefits of Omega-3 fatty acids. http://www.1st-Omega-3.Com.

Liver Disease in Cystic Fibrosis

The median age of the population with cystic fibrosis (CF) has increased worldwide, which has led to the suggestion that the prevalence of liver disease would increase. The aim of this study was to evaluate the natural history of CF-associated liver disease over a 15-year period in a well-controlled population of patients with CF. During the years 1976 through 1993, 124 patients were followed up by yearly liver function tests (LFTs). Fifteen patients were followed up with liver biopsies throughout the whole study period.
More than 50% of the patients had pathological LFTs in infancy, later being normalized. Approximately 25% of children 4 years of age or older had biochemical markers of liver disease during the study period. In about 10% of the patients, cirrhosis or advanced fibrosis was confirmed at biopsy and 4% of patients had cirrhosis with clinical liver disease.

Severe liver disease developed mainly during prepuberty and puberty. Of the 15 patients prospectively followed up with liver biopsies, only 3 had progressive fibrosis. No specific risk factor was identified, but deficiency of essential fatty acids was found more often in patients with marked steatosis (P < .05).

No patient developed clinical liver disease in adulthood and the histological changes in the liver biopsies were usually not progressive. Liver disease was no more frequent at the end of the study period although the median age of the patient population had increased.

Modern treatment might positively influence liver disease because it seemed less common, less progressive, and less serious than previously reported.

Cystic Fibrosis With Vitamins And Over The Counter Products

Cystic fibrosis is a hereditary disease that affects the entire body, causing progressive disability and early death. Cystic fibrosis affects the entire body and impacts growth, breathing, digestion, and reproduction. Difficulty breathing and insufficient enzyme production in the pancreas are the most common symptoms.

The Pancreas of patients with Cystic Fibrosis fails to produce enough enzymes that are necessary to break down food. As a result the food eaten retains its fats and most of its nutrients as it passes through the body.

The bronchial tubes in the lungs also malfunction and produce a thick, sticky mucus. Germs multiply in this mucus and cause respiratory infection such as pneumonia, accompanied by a cough and high fever that is more severe than normal.

A multitude of other symptoms, including sinus infections, poor growth, diarrhea, and potential infertility (mostly in males) result from the effects of cystic fibrosis on other parts of the body. Patients with Cystic Fibrosis also sweat profusely and their perspirations also contains an unusually high percentage of salt.

Cystic fibrosis is the most common life-limiting recessive disease among people of European heritage. Two copies of the recessive mutated gene, one from each parent is needed by the human body to develop Cystic Fibrosis.

Because cystic fibrosis testing is expensive, testing is often performed on just one parent initially. If that parent is found to be a carrier of a CFTR gene mutation, the other parent is then tested to calculate the risk that their children will have cystic fibrosis. Cystic fibrosis can result from more than a thousand different mutations and, as of 2006, it is not possible to test for each one. Most commercially available tests look for 32 or fewer different mutations.

Couples who are at high risk for having a child with cystic fibrosis; i.e. cystic fibrosis has developed in family members, will often opt to perform further testing before or during pregnancy. After birth cystic fibrosis may be diagnosed in newborn with sweat testing, or genetic testing.

Most states and countries do not screen for cystic fibrosis routinely at birth. Children with cystic fibrosis typically do not gain weight or height at the same rate as their peers and occasionally are not diagnosed until investigation is initiated for poor growth. Males tend to have a longer life expectancy than females but the reason is unknown.

Use a mask nebulizer and other inhalations treatments are the most common forms of treatments for cystic fibrosis. The goal is the treating and limiting the amount of lung damage caused by thick mucus and infection. Albuterol and ipratropium bromide are inhaled to increase the size of the small airways by relaxing the surrounding muscles. As lung disease worsens, breathing support from machines may become necessary.

Most individuals with cystic fibrosis take additional amounts of vitamins A, D, E, and K and eat high calorie meals.

Common Vitamins and over the counter products can help with treating Cystic Fibrosis such as Vitamin E, Vitamin K, Vitamin A, Lactase Enzyme, Papaya, Protein Tablets, Vitamin B, Amino Acid and L-Carnitine.

Dr. Harry Schwachman reported "most patients with cystic fibrosis have low levels of vitamin E". Vitamin E protects lung tissue form inhaled pollutants and aids the functioning of the immune system.

Vitamin K helps the blood to clot after and injury.

A number of studies have suggested that taking antioxidants such a Vitamin A reduces the risk of bronchoconstriction. Vitamin A is stored in the liver and fat cells of the human body and can reach toxic levels. DO NOT take more than the recommended dosage of Vitamin A.

Lactase Enzyme makes milk products more readily digestible.

Papaya contains lipase, which assists in Fat and Cellulose digestion.

Protein tablets increase protein intake.

All of the different Vitamin Bs taken together as B-Complex work together as a team to perform vital biological processes, such as energy production and efficient metabolic function. Vitamin B boost energy levels and help fight fatigue.

Amino Acid help regulate growth, digestion and maintaining the body's immune system.

L-Carnitine is essential for the body's ability to turn food into energy. L-Carnation increases energy at the cell level by increased fat burning, increases the body's ability to remove toxic disease-causing compounds and helps cells live longer.

Always consult your doctor before using this information.

This Article is nutritional in nature and not to be construed as medical advice.

About the Author
David Cowley has created over 50 articles about the relationship between diseases and vitamins. For other Articles on Diseases and Vitamin Needs feel free to visit my Web Site at http://www.dfcinvestment-team.com/